Filtros de búsqueda

Lista de obras de Stephane Champiat

Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential

scientific article published on 03 April 2019

Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer

scientific article published on 06 June 2019

Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?

scientific article published on 18 October 2019

Hyperprogression during immunotherapy: do we really want to know?

scientific article published on 01 July 2019

Hyperprogression upon immunotherapy: A chance for (hyper-)progress

scientific article published on 13 January 2020

Immune-checkpoints: the new anti-cancer immunotherapies ⬇️

artículo científico publicado el 1 de junio de 2013

Immune-related bone marrow failure following anti-PD1 therapy.

artículo científico publicado en 2017

Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies

artículo científico publicado en 2017

Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection

artículo científico publicado en 2012

Interventional radiology for local immunotherapy in oncology

artículo científico publicado en 2021

Intratumoral Immunotherapy: from Trial Design to Clinical Practice

scientific article published on 17 September 2020

Machine learning defined diagnostic criteria for differentiating pituitary metastasis from autoimmune hypophysitis in patients undergoing immune checkpoint blockade therapy

scientific article published on 12 August 2019

Myocarditis with Immune Checkpoint Blockade.

artículo científico publicado en 2017

Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy

artículo científico publicado en 2017

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

artículo científico publicado en 2017

Pseudoprogression in Non-Small Cell Lung Cancer upon Immunotherapy: Few Drops in the Ocean?

scientific article published on 01 March 2019

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy

artículo científico publicado en 2016

T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.

artículo científico publicado en 2013

The development of immunotherapy in older adults: New treatments, new toxicities?

artículo científico publicado en 2016

Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses

artículo científico publicado en 2009

Understanding genetic determinants of resistance to immune checkpoint blockers

artículo científico publicado en 2019

[Breaking immune tolerance in cancer]

artículo científico publicado en 2015

[Cardiac and vascular toxicity of chemotherapies]

scientific article published on 01 March 2018

[Immunotherapies and targeted therapies in medical oncology]

artículo científico publicado en 2014

[Management of adverse events associated with cancer immunotherapy]

scientific article published on 01 January 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda